841 LBL-019, a novel TNFR2 agonist antibody, shows potent anti-tumor efficacy through preferentially activating CD8+ T cells and alleviating the suppressive effect of Treg cells
Wang, Baohui, Wang, Hailin, Li, Tingting, Sun, Jianming, Huang, Xiao, Lin, Huan, Dan, Yujia, Qin, Yurong, Zhang, Peng, Guan, Jing, Wu, Guojin, Hou, Xiaofan, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Human Trophoblast and Choriocarcinoma Expression of the Growth Factor Pleiotrophin Attributable to Germ-Line Insertion of an Endogenous Retrovirus
Schulte, Anke M., Lai, Shoupeng, Kurtz, Andreas, Czubayko, Frank, Riegel, Anna T., Wellstein, Anton
Published in Proceedings of the National Academy of Sciences - PNAS (10.12.1996)
Published in Proceedings of the National Academy of Sciences - PNAS (10.12.1996)
Get full text
Journal Article
Abstract 1791: LBL-015, a novel anti-PD-1 fused with TGF-βRII, shows a great anti-tumor activity in a mouse MC38 model
Huang, Xiao, Sun, Jianming, Qin, Yurong, Lin, Huan, Guan, Jing, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model
Huang, Xiao, Sun, Jianming, Qin, Yurong, Lin, Huan, Guan, Jing, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Lbl-034, a Highly Differentiated T-Cell Engaging Bispecific Antibody Targeting GPRC5D for the Treatment of Relapsed or Refractory Multiple Myeloma
Wang, Baohui, Huang, Xiao, Sun, Jianming, Qin, Yurong, Shang, Hongyan, Li, Tingting, Wu, Guojin, Chen, Min, Wang, Hailin, Zhang, Peng, Jiang, Duqing, Liu, Tongjun, Ye, Mi, Cai, Shengli, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Complementary adenoviral vectors for oncolysis
Alemany, R, Lai, S, Lou, Y C, Jan, H Y, Fang, X, Zhang, W W
Published in Cancer gene therapy (01.01.1999)
Published in Cancer gene therapy (01.01.1999)
Get full text
Journal Article
Abstract 1867: LBL-049: A novel neutralizing antibody against GDF15 for the treatment of cachexia
Wang, Baohui, Huang, Xiao, Ding, Mi, Huang, Jing, Qin, Yurong, Li, Fengxia, Guan, Jing, Sun, Jianming, Wu, Guojin, Liu, Xiaoxiao, Zhu, Jordan, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 5523: LBL-019, a novel anti-TNFR2 antibody, shows a potent anti-tumor efficacy in a mouse MC38 model
Lin, Huan, Huang, Xiao, Qin, Yurong, Dang, Yujia, Zhang, Peng, Sun, Jianming, Guan, Jing, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 2965: LBL-033, a novel bispecific antibody targeting MUC16 and CD3, for the treatment of tumors over-expressing MUC16
Sun, Jianming, Huang, Xiao, Qin, Yurong, Fang, XingXing, Chen, Min, Lin, Huan, Guan, Jing, Huang, Jing, Liu, Tongjun, Wang, Baohui, Wu, Guojin, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 6712: LBL-043, a novel LILRB4xCD3 T cell engager, for the treatment of LILRB4 positive leukemia
Dang, Yujia, Huang, Xiao, Qin, Yurong, Liu, Xiaoya, Chen, Min, Jiang, Duqing, Wu, Guojin, Ye, Mi, Sun, Jianming, Wang, Baohui, Guan, Jing, Li, Tingting, Zhu, Jordan, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article